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Histological and Immunohistochemical Analysis of 
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 To investigate cellular growth and differentiation of the 
airway epithelium of the human fetal lung using immuno-
histochemistry, with a particular focus on cases of pulmo-
nary hypoplasia. A total of 25 autopsy cases of stillbirth and 
early neonatal death were examined at Nagasaki University 
Hospital from 1986 to 1997. Using immunohistochemistry, we 
determined the expression of a variety of growth factors 
(EGFR, HGFR, GRP and SAPA) in lung tissues with or without 
pulmonary hypoplasia. A significant decrease in radial al-
veolar count was detected in hypoplastic lungs compared 
with normal lungs. The expressions of EGFR, HGFR and GRP 
in tissues from hypoplastic lungs were significantly lower 
than in tissues from normal lungs, but the expression of 
SAPA was not different between the two groups. Our results 
indicated that significant abnormalities of cellular growth 
and differentiation are present in pulmonary hypoplasia. 
However, lung maturation in pulmonary hypoplasia was not 
significantly different to that in normal lungs.
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Introduction
 Fetal pulmonary hypoplasia is a condition character-
ized by a decrease in the number of airway epithelial 
cells, airways, and alveoli with a resulting decrease in 
organ size and weight. The condition usually develops 
as a complication of prolonged severe oligohydramnios 
caused by bilateral renal agenesis, infantile polycystic
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kidneys, posterior urethral valve or prolonged leakage 
of amniotic fluid. Pulmonary hypoplasia can be poten-
tially fatal because it is associated with an inadequate 
surface area for gas exchange. Cases of pulmonary 
hypoplasia defined as low lung weight to body weight 
ratio') account for about 10% of all autopsy cases of 
stillbirth and neonatal diseases''. Therefore, it is impor-
tant to clarify the pathogenic mechanisms of pulmo-
nary hypoplasia. 
 Fetal lung growth following tracheal obstruction, 
once believed to result in overdistension and hypertro-
phy of the lungs, seems to represent true lung hyper-
plasia. However, recently, Papadakis et al.') reported 
that replacement of tracheal fluid with saline inhibits 
lung hypertrophy seen after tracheal ligation. Indeed, 
lung weight after ligation and saline replacement was 
not significantly different from that of unobstructed 
control. This indicates that tracheal fluid composition, 
rather than intratracheal pressure, is critical in the de-
velopment of pulmonary hypoplasia.. DiFiore and Wilso 
n4> have previously shown that lung fluid after tra-
cheal ligation is mitogenic to pneumocytes in vitro. 
Although cell proliferation and lung fluid production 
is likely to be mediated by one or more growth factor 
s", their study did not establish whether humoral fac-
tors are primary or secondary effectors. Elevated intra-
tracheal pressure and pulmonary stretch could induce 
such increase in growth factor concentration. 
 The present study focused mainly on cellular deffer-
entiation of the airway epithelium of human lung using 
immunohistochemistry, with a particular emphasis on 
cases of pulmonary hypoplasia. Pulmonary hypoplasia 
was studied to determine whether structural develop-
ment of the lung is essential for epithelial cell differen-
tiation, since pulmonary hypoplasia is associated with 
in the number of bronchial branches and/or radial al-
veolar count (RAC)').
Materials and Methods
 In the cases of stillbirth and early neonatal death 
were autopsied at Nagasaki University Hospital from 
1986 to 1997, excluding those cases that were not 
suitable for the study (cases with severe pneumonia, 
hemorrhage, fibrosis, or hyaline membrane disease), 
lung tissues from 25 cases (pulmonary hypoplasia; 15 
cases, normal lungs; 10 cases) were prepared for mor-
phological examination as well as immunohistochemical 
staining. 
 For assessment of lung hypoplasia, the condition 
was defined in this study as a lung weight to body 
weight ratio of less than 0.012 at > 28 weeks of ges-
tation or less than 0.015 at < 28 weeks of gestation, 
using the criteria defined by Askenazi and Perlman'~. 
At autopsy, lungs were prepared by transbronchial 
fixation with neutral formalin. The paraffin-embedded 
left or right lung was cut into 3 p m-thick sections. 
For histological examination, tissues were stained with 
hematoxylin-eosin (HE). RAC was determined by the 
method of Emery and Mithal'). Ten to 20 counts were 
performed in each case.
Immunohistochemistry 
 Immunohistochemical studies were performed by en-
zyme histochemistry using indirect avidin-biotin com-
plex (ABC) method on formalin-fixed paraffin-embedded 
sections. Briefly, deparaffinized sections were incubated 
in 3% H202 in phosphate-buffered saline (PBS). After 
incubation with normal goat serum for mouse mono-
clonal antibody (MONO) or horse serum for rabbit 
polyclonal antibody (POLY), sections were incubated 
overnight at 4,,C with various antibodies. Antibodies 
used included rabbit anti-human epidermal growth fac-
tor receptor (EGFR, NCL-EGFR, Novocastra, Newcastle 
Upon Tyne, UK), mouse anti-human hepatocyte growth 
factor (HGF, NCL-c-MET, Novocastra), monoclonal 
mouse anti-human surfactant apoprotein A (SAPA, 
DAKO, Japan) and rabbit anti-human Gastric-Releasing 
Peptide (GRP, DAKO). As negative control, non-specific 
mouse IgG for MONO or rabbit IgG for POLY was 
used instead of each antibody. All sections were incu-
bated with biotinylated goat anti-mouse IgG for MONO 
or biotinylated horse anti-rabbit IgG for POLY (both 
from Vector Laboratories Inc., Burlingame, CA) and 
then with a solution of avidin D-biotinylated horserad-
ish peroxidase (Vector Laboratories, Inc.). Peroxidase 
activity was examined using 3,3'-diaminobenzidine 
tetrahydrochloride (Katayama Chemicals Co., Osaka, 
Japan) in PBS, containing 0.01% H2O2. Sections were 
counterstained with hematoxylin.
For evaluation of the results, immunostained sections 
were scored into one of three groups according to the 
frequency and intensity of positively stained epithelial 
cells. Frequency was defined as - and +, when the 
number of positive cells in the normal bronchus or al-
veoli in the section was <10% and >10%, respec-
tively. Intensity was defined as + when staining was 
intense. Scoring of tissue sections was performed by 
three investigators who reached an agreement on the 
areas to be analyzed. 
 Statistical analysis was performed using StatView 
software (version 4.5, Abacus Concept, Inc, Berkeley, 
CA). All data were expressed as mean ± SD. Differences 
between continuous data were examined for statistical 
significance using unpaired t-test. Categorical data 
were analyzed with the Fisher exact test or chi-square 
test as appropriate. A P value less than 0.05 denoted 
the presence of a statistically significant difference.
Results
Clinical Characteristics 
 Ten cases were assessed to be associated with nor-
mal lung growth, while 15 cases were labeled as pul-
monary hypoplasia. Fetuses of the latter group were 
more mature than those of the former group, although 
the mean gestational age of the two groups was not 
significantly different (Table 1). The causes of still-
birth and neonatal death were respiratory insufficiency 
in cases with pulmonary hypoplasia and multiple 
anomalies due to trisomy-18 in cases without pulmo-
nary hypoplasia.
Expression of EGFR 
 Staining for EGFR was detected in the basement 
membrane of epithelial cells of bronchioles (Figure 1). 
Histopathologic and immunohistochemical examination 
of lungs with pulmonary hypoplasia showed a signifi-
cant decrease in RAC and expression of EGFR relative 
to those in normal lungs (Tables 1 and 2).
Expression of HGFR(c-met) 
 Staining for HGFR was detected in the cytoplasm of 
epithelial cells of bronchioles (Figure 2). Immuno-
histochemical examination of lungs with pulmonary 
hypoplasia showed a significantly low expression of 
HGFR relative to that in normal lungs (Table 2).
Table 1. Clinical characteristics of the two groups
                               Pulmonary hypoplasia Normal lungs p 
n 15 10 
Gestational age at delivery (wk) 35.0±4.3 30.0±2.4 NS 
Body weight at birth(g) 1810±565 1224±113 <0.05 
Lung weight/body weight ratio 0.008±0.002 0.022±0.004 <0.01 
Radial alveolar count 1.77±0.17 2.96±0.37 <0.01
Data are mean ± SD. NS:not significant.
Figure 1. Top: A representative case of pulmonary hypoplasia. 
         Note the expression of EGFR in the bronchiole. The 
         intensity of staining was judged as +. Bottom: A rep
         resentative case without pulmonary hypoplasia. Note
         the lack of EGFR expression. (Immunoperoxidase
         and hematoxylin, magnification 200).
Figure 2. Top: A representative case of pulmonary hypoplasia. 
         Note the expression of HGF-R in the bronchiole. The 
         intensity of staining was judged as +. Bottom: A rep 
         resentative case without pulmonary hypoplasia. Note
         the lack of HGF-R expression. (Immunoperoxidase
         and hematoxylin, magnification - 200).
Expression of GRP 
 GRP-containing cells formed corpuscular apparatuses 
either in bronchi lacking cartilage or in bronchioles, al-
though some GRP-containing cells were present as sin-
gle cells (Figure 3). Morphologically, the corpuscles 
were round, elongated, or irregular in shape and con-
sisted of four or more GRP-containing cells. Character-
istically, corpuscle cells protruded into the subepithelial 
connective tissue. The unique histologic features of
these corpuscles resembled those of "neuroepithelial 
bodies" described by Lauweryns et al.'). Tissues from 
hypoplastic lungs showed a significant decrease in the 
expression of GRP relative to that in normal lungs 
(Table 2).
Expression of SAPA 
 SAPA positive cells in alveoli stained as strong as 
those in the bronchial epithelium (Figure 4). The
Figure 3. Top: A representative case of pulmonary hypoplasia. 
         Note the expression of GRP in the bronchiole. The in-
         tensity of staining was judged as +. Bottom: A repre-
         sentative case without pulmonary hypoplasia. Note 
         the lack of GRP expression. (Immunoperoxidase and
         hematoxylin, magnification 200).
Figure 4. Top: A representative case of pulmonary hypoplasia. 
         Note the expression of SAPA in the alveoli. The in-
         tensity of staining was judged as +. Bottom: A repre-
         sentative case without pulmonary hypoplasia. Note 
         the lack of SAPA expression. (Immunoperoxidase
         and hematoxylin, magnification _ 200).
Table 2. Expression of each factors in hypoplastic and normal lungs.
                    Pulmonary hypoplasia Normal lungs 
                   (%) (%) p* 
n 15 10 
EGF-R 
     Intensity 4(27) 8 ( 80) < 0.05 
      Frequency 1( 7) 7 ( 70) <0.01
HGF-R 
     Intensity 7(47) 10(100) < 0.05 
      Frequency 3(20) 10(100) <0.01
GRP 
     Intensity 12(80) 10(100) NS 
      Frequency 8(53) 10(100) < 0.05 
SAPA 
     Intensity 7(47) 8 ( 80) NS 
     Frequency 5(33) 6( 60) NS
Data are nimber of cases while numbers in parentheses represent the percentage of cases. 
*Fisher exact and x2 tests 
NS:not sighnificant.
expression of SAPA in tissues from hypoplastic lungs 
tended to be lower than that in normal lungs, al-
though the difference was not statistically significant 
(Table 2).
Discussion
 Epidermal growth factor (EGF) is a biologically ac-
tive polypeptide first described in 1962 by Cohen9} . 
The biologic effects of EGF are primarily those of gen-
eralized epithelial growth and keratinization. In 1975, 
EGF was considered as a growth hormone capable of 
stimulating the growth of epithelial cells in fetal"). It 
was shown that constant infusion of EGF into fetal 
lamb for 3-5 days stimulated epithelial growth in many 
sites, including upper and lower airways. In addition, 
EGF appeared to protect the hyaline membrane against 
the development of hyaline membrane disease when 
administered in utero at 123-130 days of gestation"), 
suggesting that EGF stimulated cell differentiation in 
addition to promoting cell growth. 
 GRP, first extracted from porcine gastric mucosa by 
McDonald et al" in 1978, consists of 27 amino acid 
residues, and its biologically active C-terminal tetra-
decapeptide amide possesses a very similar amino acid 
sequence to amphibian bombesin'"). GRP has now been 
added to a growing list of brain-gut peptides. The bio-
logic actions of GRP, which are similar to those of 
bombesin and have only been partially characterized"), 
include stimulation of secretion of gastrin, insulin, pan-
creatic polypeptide, and enteroglucagon; as well as 
contraction of smooth muscles of blood vessels and 
gallbladder; and stimulation of pancreatic enzyme se-
cretion. Bombesin also stimulates bronchial contraction"). 
To our knowledge, the influence of these factors on 
fetal pulmonary growth has not been previously re-
ported. Therefore, in the present study, we focused on 
cellular growth and differentiation of the airway epi 
thelium of human fetal lung using immunohistochemistry, 
focusing particularly on cases of pulmonary hypoplasia. 
Our results showed that in spite of advanced gestational 
age, tissues from hypoplastic lungs showed signifi-
cantly low expressions of EGFR, HGFR and GRP rela-
tive to those in lungs without hypoplasia. These re-
sults suggest that intrapulmonary epithelial cell 
differentiation is closely related to the formation of 
lung structure. 
 Endo and Oka16) reported the results of histological 
and immunohistochemical analysis of lung develop-
ment in lung hypoplasia using antibody for epithelial 
membrane antigen, keratin, Leu-7, Ca 19-9, secretary 
component and SAPA. In their study, two of six cases
with lung hypoplasia showed deviation from normal in 
the pattern of immunohistochemical staining, which 
was probably related to abnormal cellular differentia-
tion, similar to the results reported in our study. 
However, in the same study, four of their cases with 
lung hypoplasia showed a normal or near-normal 
immunohistochemical staining. 
 In conclusion, we demonstrated in the present study 
that pulmonary hypoplasia was associated with abnor-
mal cellular growth and differentiation as demonstrated 
by low expression of a variety of growth factors. 
However, lung maturation in pulmonary hypoplasia was 
not significantly different to that in normal lungs-
Because the conclusions of this study this study are 
weaked by the small sample size and few antibody for 
immunohistochemical staining, more studies are needed 
to explain the abnormal cellular growth and differen-
tiation in pulmonary hypoplasia.
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